The measurement of salivary cortisol levels is an attractive way of testing adrenal function in infants and children. It provides a reliable tool for the determination of the physiology and developmental characteristics of cortisol metabolism.
As the cortisol and DHEA levels in saliva reflected those in serum, the measurement of steroid levels in saliva provide a useful and practical tool to evaluate adrenal functions, which are essential for clinical diagnosis.
salivary testing of cortisol proven to be a better test than blood cortisol. Published in Clinical Endocrinology, '05. Salivary cortisol testing is best test to evaluate cortisol levels.
Animal study finds that Bisphenol A exposure in utero has profound different effects in male offspring versus female offspring. In the male offspring there appears to be an up regulation of the HPA axis. The opposite appears true in the female off spring. Additionally, the receptors are effected differently as well.
Only abstract available. Meta-analysis of Testosterone therapy in post-menopausal women finds significant bias, some improvement in sexual function and cholesterol levels, yet safety and long-term data is significantly lacking. Take this with studies on endogenous Testosterone in women, significant caution needs to be followed with Testosterone in women. Only abstract available here.
Study finds 50 mg of DHEA improves insulin sensitivity in Hypoadrenal women. The authors also found and increase in DHEAS, bioavailable T, androstenedione, and a reduced SHBG, insulin, and glucagon.
insulin is an important inhibitor of the synthesis of SHBG
no correlation between leptin and SHBG levels
SHBG reduction in obesity is a minor determinant of lowered androgen levels
SHBG can explain only up to 3% of the correlation
testicular T de novo production is impaired in obese men and that leptin seems to be the best hormonal predictor of this blunted response to LH stimulation
The low basal 17-OH-P levels found in massively obese men are consistent with a global impairment of Leydig cell steroidogenic function in this group of subjects.
These findings indicate that obese men have a FM-related defect in the enzymatic conversion of 17-OH-P to T, which is revealed by hCG stimulation.
Other studies have investigated the adrenal function in male obesity and have shown that basal cortisol and 17-OH-progesterone levels tend to decrease with the increase in the degree of obesity
High E2 can inhibit the expression and activity of the 17,20-lyase and may be responsible for this steroidogenic lesion
However, stimulated E2 levels were not higher in the obese than in controls, excluding the fact that the lower androgen response was due to an increased aromatization of T to E2 and that estrogens have a major role in the observed defect of 17,20-lyase activity in obese men.
the percentage increase in the 17-OH-progesterone to T molar ratio paralleled the increase in leptin levels of obese men
Multiple regression analysis indicated that the best hormonal predictor of the obesity-related reduction in T and FT basal levels and androgen changes after hCG stimulation was serum leptin concentration
insulin has no negative influences on androgen production in obese men
insulin is known to have stimulatory actions on T production that have been demonstrated in obese and normal weight men (57) and in Leydig cells in culture
the negative correlation between insulin and basal T can be partly explained by the inhibitory action of insulin on SHBG production
hypogonadal men have higher circulating leptin levels compared with hypogonadal patients under effective androgen substitution therapy
The impaired androgen response to LH stimulus was due to a defect in the enzymatic conversion of 17-OH-progesterone to T, which was disclosed by a leptin-related increase in 17-OH-progesterone to T ratio
Estrogens, which are inhibitory modulators of LH pulsatility and bioactivity
Leptin appears to be a good marker of low Testosterone. This study proposes that the mechanism of action is potentially 2 fold: first, a decrease in LH release by leptin (kisspeptin?) and 2nd, a directed decrease in Testosterone production by the leydig cells in the testes.
crucial role of the RAS in the development and maintenance of cancer
kidneys, which produce renin in response to decreased arterial pressure, reduced sodium in the distal tubule, or sympathetic nervous system activity via the β-adrenergic receptors
Renin is secreted from the juxtaglomerular cells into the bloodstream where it encounters angiotensinogen (AGN), normally produced by the liver
Renin catalyses the conversion of AGN to angiotensin I (ATI), which is quickly cleaved by angiotensin converting enzyme (ACE) to form angiotensin II (ATII)
ATII triggers the release of aldosterone from the adrenal glands, which stimulates reabsorption of sodium and water and thereby increases blood volume and blood pressure
ATII also acts on smooth muscle to cause vasoconstriction of the arterioles
ATII promotes the release of antidiuretic hormone from the posterior pituitary gland, which results in water retention and triggers the thirst reflex
ability of non-CSCs to ‘de-differentiate’ into CSCs due to epigenetic or environmental factors, which further increases the complexity of tumour biology and treatment
efficacy of RAS modulators on cancer in both cancer models and cancer patients
A localised (‘paracrine’) RAS mechanism has been identified in many types of cancers, and interruption of the control of the RAS is thought to be the basis for its role in cancer
Components of the RAS are expressed by these CSCs, supporting the hypothesis of the presence of a ‘paracrine RAS’ in regulating these CSCs
Renin is an enzyme normally released by the kidneys in response to falling arterial pressure
a study of GBM demonstrating overexpression of PRR coupled with the observation that inhibition of renin reduces cellular proliferation and promotes apoptosis
PRR has been found to be vital for normal Wnt signalling
A major focus of PRR research is its relationship with Wnt signalling
suggest a crucial role for PRR activation on the proliferation of CSCs, possibly via Wnt/β-catenin signalling, leading to carcinogenesis.
Angiotensin converting enzyme (ACE), also known as CD143, is the endothelial-bound peptidase which physiologically converts ATI to ATII
ACE is crucial in the regulation of blood pressure, angiogenesis and inflammation
results suggest that an overactive ACE promotes cancer growth and progression, and an inhibited or low-activity ACE may have cancer-protective effects
When bound to ATII or ATIII it causes vasoconstriction by stimulating the release of vasopressin, reabsorption of water and sodium by promoting secretion of aldosterone and insulin, fibrosis, cellular growth and migration, pro-inflammation, glucose release from the liver, increased plasma triglyceride concentration, and reduced gluconeogenesis
ATIIR1 is a G-protein-coupled receptor, with downstream signalling involved in vasodilation, hypertrophy and NF-κB activation leading to TNF-α and PAI-1 expression
ATIIR1 has well-documented links with cancer, with one study demonstrating its overexpression in ~20% of breast cancer patients
the effect of RAS dysregulation has been associated with increased VEGF expression and angiogenesis in cancers
In ovarian and cervical cancer, ATIIR1 overexpression has been shown to be an indicator of tumour invasiveness
administration of ATIIR1 blockers (ARBs) have been associated with reduced tumour size, reduction in tumour vascularisation, lower occurrence of metastases, and lower VEGF levels
Alterations in the HPA and hypothalamic-pituitary-gonadal axes with a resultant decrease in testosterone:cortisol ratios have been implicated in OTS. Proinflammatory cytokines are potent activators of the HPA system, which cause release of corticotropin-releasing hormone, adrenocorticotropic hormone, and cortisol. These cytokines suppress testosterone through central inhibition
Some have suggested that a decreased testosterone:cortisol ratio can be diagnostic of NFO and/or OTS. However, the ratio represents the physiologic strain of training rather than the athlete’s maladaption to that stress
Cortisol (catabolic and anti-inflammatory) is converted to inactive cortisone by 11β-HSD2
A prospective study found a clinically significant increase in overnight urinary cortisol:cortisone ratio during a high training load period in triathletes, who subsequently underperformed and reported fatigue
It is proposed that cytokines may inhibit 11β-HSD2 activity and result in relative increases in cortisol and, hence, catabolism
Endocrine Disrupting Chemicals from 1970 still disrupting hormones today. Three fold increase in DHEA in 3 year old children via saliva and androstenedione in mothers compared to controls.
the reduction in BP within the first 10–20 min may be primarily attributed to a direct vasodilatory physiological effect, described as venodilation
BP reduction observed after 70–90 min is likely attributable to pharmacokinetically plausible vitamin C absorption and vasodilation because of nitric oxide release
Pharmacokinetic studies of IVC administration observed peak plasma levels within the first 90 min, with plasma levels reaching 13350 μmol/l for 50 g of IVC
Essential hypertension, associated with endothelial dysfunction because of an impaired nitric oxide/l-arginine pathway and impaired vasodilation can be restored by vitamin C
marked increase in BP response when IVB12 is administered
The mean BP increased significantly up to 12–16 mmHg systolic and diastolic independent of the dosage of vitamin B12
The production of norepinephrine, which can stimulate angiotensin-II production, which in turn influences BP, has been suggested as a possible mechanism for the increase in BP with IVB12
excess norephinephrine levels stimulate the sympathetic nervous system, leading to increased cortisol production, which has also been linked to increases in BP
Animal studies have found higher serum levels of norepinephrine (noradrenaline) in the adrenal medulla of rats receiving methylcobalamin (methyl-vitamin B12)
IV vitamin C in mostly normotensive patients (> 30 grams) reduced blood pressure. Some of the patients were pre-hypertensive. Vitamin B12 increase the blood pressure.
surgery per se can promote cancer metastasis through a series of local and systemic events
surgery results in a serious wound that disrupts the structural barrier preventing the outspreading of cancer cells, change the properties of the cancer cells and stromal cells remaining in the tumor microenvironment, or impairs the host defense systems against cancers
Key point; add to presentation on surgery and metastasis
After the primary tumor is surgically removed, the metastases can start to grow vigorously via neoangiogenesis because the circulating inhibitors disappear
infection and inflammation during the postoperative period have been reported to increase the risk of cancer recurrence in patients
Surgeons have long suspected that surgery, even if it is a necessary step in cancer treatment, facilitates cancer metastasis
Surgery-induced cancer metastasis has been well established in animal models
tumor cell dissemination, tumor-favoring immune responses, and neoangiogenesis
the surgical resection of primary tumors is beneficial is controversial
CTCs abruptly increase just after surgery
Even externally palpitating tumors for diagnosis could increase the numbers of CTCs in skin cancer and breast cancer
immune surveillance against tumors is considered to be impaired by surgical stress
In addition to glucocorticoids, during stimulation of the HPA axis, the catecholamine hormones epinephrine and norepinephrine are released from the adrenal medulla
NK cell suppression may be attributed to increased levels of catecholamines as well as glucocorticoids
In mice bearing a primary tumor, it was observed that the removal of the primary tumor facilitated the growth of highly vascularized metastases
primary tumors may secrete angiogenic inhibitors as well as angiogenic activators
second phase of tumor recurrence and metastasis, which are newly acquired events, rather than just outcomes of incomplete treatment.
HIF-1 in neutrophils plays a critical role in NETosis and bacteria-killing activity
neutrophils play various roles in the initiation and progression of cancer
NETosis
many inflammatory and neoplastic diseases
formation of neutrophil extracellular traps (NETs), which are large extracellular complexes composed of chromatin and cytoplasmic/granular proteins1
NETosis has been highlighted as an inflammatory event that promotes cancer metastasis
Once activated, neutrophils produce intracellular precursors by using DNA, histones, and granular and cytoplasmic proteins and then spread the mature form of NETs out around themselves
Neutrophils are the most abundant type of granulocytes, comprising 40–70% of all white blood cells
two types of NEToses, suicidal (or lytic) NETosis and vital NETosis
Suicidal NETosis mainly depends on the production of reactive oxygen species (ROS)
Since neutrophils die during this process, it is called suicidal NETosis.
vital NETosis
vital NETosis occurs independently of ROS production
Vital NETosis can be induced by Gram-negative bacteria. LPS
NETs are present in a variety of cancers, such as lung cancer, colon cancer, ovarian cancer, and leukemia
neutrophils actively undergo NETosis in the tumor microenvironment
Hypoxia
NETosis plays a pivotal role in noninfectious autoimmune diseases,
cytokines
tumor-derived proteases
tumor exosomes
NETosis generally actively progresses in the tumor microenvironment.
the proliferative cytokines TGFβ and IL-10 and the angiogenic factor VEGF are representative of neutrophil-derived tissue repair proteins.
NETosis is a defense system to protect the body from invading pathogens
when neutrophils are excessively stimulated, they produce excess NETs, thereby leading to pathological consequences
plasma levels of NETosis markers are elevated after major surgeries
local invasion, intravasation into the blood or lymphatic vessels, escape from the immune system, anchoring to capillaries in target organs, extravasation into the organs, transformation from dormant cells to proliferating cells, colonization to micrometastases, and growth to macrometastases
NETs promote metastasis at multiple steps
NETs loosen the ECM and capillary wall to promote the intravasation of cancer cells
NETs and platelets wrap CTCs, which protects them from attack by immune cells and shearing force by blood flow
NETs promote the local invasion of cancer cells by degrading the extracellular matrix (ECM)
neutrophil elastase, matrix metalloproteinase 9, and cathepsin G
NETs also promote the intravasation of cancer cells
millions of tumor cells are released into the circulation every day,
NETs can wrap up CTCs with platelets
β1-integrin plays an important role in the interaction between CTCs and NETs
NET-platelet-CTC aggregates.
After metastasizing to distant tissues, tumor cells are often found to remain dormant for a period of time and unexpectedly regrow late
NETs are believed to participate in the reactivation of dormant cancer cells in metastatic regions
NET-associated proteases NE and MMP-9 were found to be responsible for the reactivation of dormant cancer cells